James C. Shehan is quoted in an article discussing high drug prices and Congressional activity aimed at driving down rising costs. In The American Journal of Managed Care, his interview with The Center for Biosimilars is referenced, with Shehan commenting that the U.S. Congress has been “all talk and no action” for the last decade. States, however, Shehan notes, have taken concrete action on drug pricing, with almost every state having considered some kind of proposal and a number of laws enacted.
Relevant Insights
-
PROFESSIONALS | Lawyers
Access the profiles of the more than 350 Lowenstein Sandler lawyers who provide critical legal counsel to clients in virtually every sector of the global economy...
-
NEWS & INSIGHTS | Firm News
Discover the latest updates and developments about Lowenstein Sandler...
-
NEWS & INSIGHTS | Publications
Access our insightful thought leadership, including articles, client alerts, and blog posts...